Acme United

Intangible assets: Westcott, First Aid Only, Spill Magic, DMT and related trademarks are long-lived and supported by patents and product know-how. Westcott is a leading scissor and ruler brand in North America, while First Aid Only’s SmartCompliance systems and SafetyHub app embed compliance and replenishment.

We view brand and regulatory know-how as the primary moat pillars (intangible assets ~70/100). Switching costs: In first aid, OSHA/ANSI compliance plus bar-code and app-enabled replenishment raise switching frictions for workplaces and multi-site customers, though alternatives exist; we rate switching costs as moderate (60/100).

Network effects: limited to app and distributor relationships, not true two-sided networks (10/100). Cost advantages: partial vertical integration (Med-Nap wipes), robotics, and a new Tennessee facility for Spill Magic improve unit economics over time, but scale is modest versus larger peers (55/100).

Efficient scale: several categories are niche with rational capacity, but big-box and e-commerce channels reduce barriers (50/100). Weighted, we see a narrow, defendable moat primarily in first aid compliance and select cutting niches, with the risk of erosion from larger competitors (3M, Fiskars; Honeywell, Cintas) and channel power.

Gross margin reached ~39.4 percent in 2025 and 39.7 percent in Q1 2026 as mix favored first aid and medical, and ACU benefits from branded positioning in many SKUs. However, retailer concentration curtails unilateral price action and tariff pass-through can lag.

First aid compliance kits and refills have better stickiness and value-in-use than commodity cutting tools, implying selective pricing power rather than broad-based.

We see room for continued mix-led expansion as Elite and My Medic integrate, Tennessee capacity ramps, and robotics lower costs, but we stay conservative given competitive sets and procurement pressures.

Revenue is diversified across first aid and cutting tools, with seasonality tied to back-to-school in Q2–Q3 for cutting, while first aid replenishment supports steadier cadence year round. Management notes that first and fourth quarters are typically weaker.

Two customers were ~13 percent each of 2025 sales and three customers comprised 17, 13 and 11 percent of receivables, which adds lumpiness risk. Still, first aid has recurring characteristics, and TTM revenue through Q1 2026 grew to about 203 million dollars (+3 percent vs. 2025) even with tariff headwinds.

We view mid single-digit organic growth plus bolt-ons as a reasonable medium-term base case.

As of March 31, 2026, revolver borrowings were about 33.0 million with mortgage debt near 9.9 million; cash was ~4.2 million, for net debt around 38.6 to 38.8 million.

Covenants appear manageable, the current ratio stood at 4.57 and the long-term debt-to-equity ratio was ~36 percent. 2025 operating income was 14.7 million with interest expense of 1.56 million, suggesting healthy interest coverage. We note a 2024 material weakness in ICFR was remediated by year-end 2025 per the 2026 10-K auditor opinion.

Elevated capex in 2025–2026 reflects growth investments; free cash flow should improve as integration and capex normalize.

Capital deployment has emphasized tuck-in acquisitions at modest sizes, capacity additions and automation, alongside a rising but modest dividend (0.16 dollars per quarter declared March 12, 2026). Buybacks have been minimal since 2019 authorization and we prefer this focus on reinvestment while leverage is elevated post-My Medic.

My Medic cost 18.6 million (14.4 million cash plus holdback and earnout) and contributed 3.4 million revenue in Q1 2026; Elite First Aid and a German cutting line broaden product offerings and geographies. We view the M&A track record as prudent, with synergy capture and working-capital discipline as the key near-term proof points.

CEO Walter C. Johnsen has led since 1995 through multiple cycles and successful portfolio repositioning toward first aid. Alignment is strong: he beneficially owns roughly 658,499 shares, about 15.9 percent of outstanding, and the senior team has long average tenures.

Governance is standard for a small-cap manufacturer and incentives are equity-linked. Execution risks remain around integration, tariffs and large retail customers, but we rate management quality and owner-operator alignment as clear positives.